Clinical Trial: Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557498) titled 'Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US' on April 23.

Brief Summary: The purpose of this study is to understand the real-world clinical outcomes and treatment patterns of adults with obstructive hypertrophic cardiomyopathy (HCM) treated with mavacamten, and to understand patient and physician experiences with mavacamten treatment, in the US community-based practice

Study Start Date: Jan. 15

Study Type: OBSERVATIONAL

Condition: Obstructive Hypertrophic Cardiomyopathy (oHCM)

Intervention: DRUG: Mavacamten

According to the product label

Recruitment...